drugset / Trial / NCT01143168
Stem Cell Therapy for Type 1 Diabetes Mellitus
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the feasibility, efficacy and safety of transplantation therapy using bone marrow mononuclear cells and umbilical cord mesenchymal stem cells for patients with type 1 diabetes mellitus
Timeline
- Start
- 2010-08
- Primary completion
- 2011-08
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | autologous bone marrow mononuclear cells | Cell therapy | — | Other |
| Subject | mesenchymal stem cells | Cell therapy | — | Other |